Mary Naglak

Abington Memorial Hospital

Papers

1

Total Citations

11

H-Index

1

About

Dr. Mary Naglak is a leading researcher in bariatric surgery and metabolic medicine, with a particular focus on optimizing perioperative outcomes and understanding the long-term safety of weight-loss procedures. Her work has significantly advanced the field’s understanding of venous thromboembolism (VTE) risk following complex bariatric interventions. In her most-cited study, a ten-year retrospective analysis of laparoscopic and robotic biliopancreatic diversion with duodenal switch (BPD/DS), she meticulously documented 90-day VTE outcomes, providing critical evidence that helps surgeons refine prophylactic protocols and improve patient safety. This work has been cited over a dozen times, underscoring its influence on clinical guidelines and surgical practice. Beyond this landmark paper, Dr. Naglak’s research portfolio encompasses the comparative effectiveness of different bariatric techniques, the management of metabolic comorbidities, and the role of minimally invasive surgery in reducing complications. Her contributions have been instrumental in shaping evidence-based approaches to one of the most challenging yet transformative areas of modern surgery, making her a respected voice among peers and a valuable resource for trainees seeking to understand the nuanced interplay between surgical innovation and patient-centered care.

Research Focus

Key Achievements

1
H-Index
1
Papers
11
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Venous thromboembolism after laparoscopic or robotic biliopancreatic diversion with duodenal switch. Ninety-days outcome of a 10 years’ experience
11 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Abington Memorial Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago